
Opinion|Videos|August 21, 2024
Navigating the Clinical and Economic Landscape of Hepatic Encephalopathy (HE)
HE poses significant clinical and economic burdens, with admissions costing tens of thousands of dollars and frequent readmissions, impacting patients, caregivers, and the healthcare system.
Advertisement
Episodes in this series

This series was supported by Salix Pharmaceuticals.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
5





